Comparison
2q13 Microdeletion Syndrome C6012360 vs 15q14 Microdeletion Syndrome C4305230
Clinical comparison between 2q13 Microdeletion Syndrome and 15q14 Microdeletion Syndrome for differential diagnosis and treatment planning.
2q13 Microdeletion Syndrome C6012360
A rare genetic condition where a small piece of chromosome 2 is missing. It can affect development and cause distinctive features. Care involves multiple specialists based on symptoms.
15q14 Microdeletion Syndrome C4305230
A rare chromosomal condition where a small piece of chromosome 15 is missing. It can be associated with congenital heart defects, developmental delays, and distinctive facial features. Care focuses on addressing specific health and developmental needs.
6 comparison axes
Onset
2q13 Microdeletion Syndrome C6012360
Variable
15q14 Microdeletion Syndrome C4305230
0-null
Onset patterns differ
Severity
2q13 Microdeletion Syndrome C6012360
severe
15q14 Microdeletion Syndrome C4305230
moderate
Different severity levels
Chronic
2q13 Microdeletion Syndrome C6012360
Chronic
15q14 Microdeletion Syndrome C4305230
Chronic
Differing course
Communicable
2q13 Microdeletion Syndrome C6012360
No
15q14 Microdeletion Syndrome C4305230
No
Different transmission
Body System
2q13 Microdeletion Syndrome C6012360
congenital
15q14 Microdeletion Syndrome C4305230
congenital
Same/different system
Category
2q13 Microdeletion Syndrome C6012360
rare-disease
15q14 Microdeletion Syndrome C4305230
genetic
Different category
Bottom line
2q13-microdeletion-syndrome-C6012360 and 15q14-microdeletion-syndrome-C4305230 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q13 Microdeletion Syndrome C6012360 | 15q14 Microdeletion Syndrome C4305230 | Discriminating power |
|---|---|---|---|
| Chromosomal locus | Missing material involving chromosome 2q13 | Missing material involving chromosome 15q14 | High |
| Described associations | Developmental effects and distinctive features are mentioned; a specific pattern is not established | Congenital heart defects, developmental delay, and distinctive facial features are described associations | Moderate |
| Severity label | Source label is severe, but this does not define every case | Source label is moderate, but individual impact may vary | Low |
When to favor each condition
Choose 2q13 Microdeletion Syndrome C6012360 when
Testing identifies a deletion at 2q13
The chromosomal locus is the principal discriminator
High
Developmental concerns occur without a 15q14 finding
2q13 should be considered only when genetic results support it
Moderate
Care planning follows a confirmed 2q13 deletion
Management is individualized and specialist-based
Moderate
Choose 15q14 Microdeletion Syndrome C4305230 when
Testing identifies a deletion at 15q14
The locus distinguishes it from a 2q13 deletion
High
Heart defect or developmental delay accompanies a relevant genetic result
These are described associations, not proof without confirmation
Moderate
Confirmed 15q14 deletion requires needs-based care
Evaluation should address cardiac and developmental findings
Moderate
How key tests differ
| Test | 2q13 Microdeletion Syndrome C6012360 | 15q14 Microdeletion Syndrome C4305230 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May show copy-number loss at 2q13 | May show copy-number loss at 15q14 | Locus and laboratory confirmation distinguish the conditions |
| Targeted genetic confirmation | Confirms a chromosome 2 finding when indicated | Confirms a chromosome 15 finding when indicated | Method selection requires genetics and laboratory judgment |
| Organ-system assessment | No single abnormality is established by this source | Cardiac assessment is relevant because heart defects are described | Abnormal results are findings, not standalone diagnoses |
Prognosis comparison
2q13 Microdeletion Syndrome C6012360
- Outcome
- Long-term outcome is not established from the supplied data.
- Factors
- Severe source label, developmental effects, and individual findings.
15q14 Microdeletion Syndrome C4305230
- Outcome
- Outcome is not established; impact is described as potentially moderate but variable.
- Factors
- Heart defects, developmental delay, facial features, and support needs.
Time frame: Both are chronic; exact onset is variable or not established.
Deletion details, associated anomalies, therapies, and follow-up influence course.
Complications comparison
| Complication | Presentation |
|---|---|
| Development | Developmental effects are possible Developmental delay is a described association Range and severity are not established for every person |
| Congenital anomalies | Distinctive features may occur; specifics are not established here Congenital heart defects are a described association Findings require clinician interpretation |
| Support needs | Chronic needs may be substantial Chronic needs may be moderate but variable Source severity labels do not predict individual outcome |
Patient education highlights
- HighConfirmation
Diagnosis depends on a confirmed chromosomal deletion and genetics counseling.
- HighCare
Neither condition is contagious; care follows the person’s specific findings.
- MediumUncertainty
Available descriptions are limited, so broad severity labels should not be overinterpreted.